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Background
Late gadolinium enhancement (LGE) during contrast-
enhanced cardiac magnetic resonance (CMR) imaging is
a powerful predictor of adverse event. However, there
are limited data regarding the incidence and prognostic
significance of LGE in patients with atrial fibrillation
(AF). Furthermore, while CMR is one of the modalities
employed in characterizing pulmonary venous anatomy
in patients being considered for radiofrequency ablation
therapy, the prognostic significance of an incidental
finding of abnormal LGE is unclear. Therefore, our
study has 2 aims: 1) to identify the frequency of unanti-
cipated LGE in patients with AF and 2) to determine
whether identification of LGE in this population could
provide important prognostic information.
Methods
We performed clinical follow-up on 675 consecutive
patients referred for a CMR in preparation for pulmonary
vein isolation between September 2005 and March 2011.
The clinical end-point of interest was all-cause mortality.
Patients with prior myocardial infarction (MI) by clinical
history or EKG were excluded. Considering all the signifi-
cant variables on univariable analysis, we sought the best-
overall multivariate models for patient mortality. After
excluding patients with MI by clinical history or EKG, all
patients were included with all distributions of LGE.
Results
Fifty five patients (8%) had evidence of a prior MI and
were excluded. Of the remaining 620 patients, 73% were
male with an average age of 56 years, a BMI of 30±5
kg/m2, a left ventricular (LV) end-diastolic volume of
167±42 mls, an LV mass index of 65±12 gms/m2, and a
LV ejection fraction of 56±10%. Of these, 311 patients
(50%) had a history of hypertension, 96 (15%) had dia-
betes, 120 (19%) had sleep apnea, and 156 (25%) had a
history of heart failure. LGE was found in 80 patients
(13%). There were 61 deaths over a median follow-up
period of 42 months. On univariable analysis, age (HR
1.03, CI 1.00-1.06, chi-squared 5.83, P=0.02), diabetes
(HR 2.51, CI 1.44-4.36, chi-squared 10.6, P=0.001), heart
failure (HR 1.72, CI 1.02-2.90, chi-squared 4.1, P=0.04),
the presence of LGE (HR 8.52, CI 4.18-12.2, chi-squared
25.8, P<0.0001), and the extent of LGE (HR 1.15, CI
1.10-1.21, chi-squared 35.6, P<0.0001) provided the
strongest association with mortality. In a multivariate
model, LGE was the strongest multivariable predictor of
mortality. Each adjusted 1% increase in LGE was asso-
ciated with a 15% increased risk of death.
Conclusions
In patients with atrial fibrillation and without a prior his-
tory of MI, LGE is a frequent finding and is a powerful
predictor of mortality. These data support the robust
prognostic value of CMR for patients prior to radiofre-
quency ablation of atrial fibrillation, and support the need
for further workup in patients with high-risk findings.
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